• Caballero D, Campo E, López-Guillermo A, Martín A, Arranz-Sáez R, Giné E, López A, González-Barca E, Canales MA, González-Díaz M, Orfao A.Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group. Ann Hematol. 2013 Mayo 29. [Epub ahead of print].

  • Arranz R, García-Noblejas A, Grande C, Cannata-Ortiz J, Sánchez JJ, García-Marco JA, Aláez C, Pérez-Calvo J, Martínez-Sánchez P, Sánchez-González B, Canales MA, Conde E, Martín A, Arranz E, Terol MJ, Salar A, Caballero D. First line treatment with rituximab- Hyper-CVAD alternating with rituximab- Methotrexate- Cytarabine and followed by consolidation with 90Y-Ibritumomab-Tiuxetan in patients with mantle cell lymphoma. Results of a phase 2 pilot multicenter trial from the GELTAMO group. Haematologica. 2013 Jun 10. [Epub ahead of print].

  • Alcoceba M, Sebastián E, Marin LA, Balanzategui A, Sarasquete ME, Chillon MC, Jiménez C, Puig N, Corral R, Pardal E, Grande C, Bello JL, Albo C, de la Cruz F, Panizo C, Martín A,  González-Barca E, Caballero MD, San Miguel JF, García-Sanz R, González M. HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma. Blood 2013 (in press).

  •  E. Pardal, C. Grande, A. Martin, A. Marin-Niebla, C. Panizo, E. Conde, J. Bello, M. He rnandez, E. Pe rez, E. Gonzalez-Barca, R. Arranz, J. Bargay, M. Ramirez, A. Salar, M. Canales, M. Caballero. Treatment descalation based on early FDGPET in patients with poor risk diffuse large B cell lymphoma (DLBCL). A prospective phase II GELTAMO trial. Ann Oncol 2011; 22 (suppl 4): abstr 330

  • J. M. Calvo-Villas, A. Martín, E. Conde, A. Pascual, I. Heras, R. Varela, J. de la Rubia, M. J. Ramirez, J. L. Díez-Martín, C. Panizo, M. J. Rodríguez-Salazar, M. J. Pascual, E. M. Donato, E. González-Barca & M. D. Caballero on behalf of the Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea (GEL/TAMO cooperative group). Effect of addition of rituximab to salvage chemotherapy on outcome of patients with diffuse large B-cell lymphoma relapsing after an autologous stem-cell transplantation. (110.96 kB) Annals of Oncology (Marzo 15, 2010)

  • Martín A, Conde E, Arnan M, Canales MA, Deben G, Sancho JM, Andreu R, Salar A, García-Sanchez P, Vázquez L, Nistal S, Requena MJ, Donato EM, González JA, León A, Ruiz C, Grande C, González-Barca E, Caballero MD. On behalf of the ‘Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea’ (GEL/TAMO cooperative group). R-ESHAP as salvage therapy for patients with relapsed or refractory Diffuse Large B-cell Lymphoma: Influence of prior exposure to rituximab on outcome (a GEL/TAMO study). Haematologica 2008; 93: 1829-36.

  • Martín A, Conde E, Arnan M, Canales MA, Deben G, Sancho JM, Andreu R, Salar A, García-Sanchez P, Nistal S, Requena MJ, Donato EM, González JA, León A, Ruiz C, Grande C, Caballero MD. On behalf of the ‘Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea’ (GEL/TAMO cooperative group). R-ESHAP as salvage therapy for patients with relapsed or refractory Diffuse Large B-cell Lymphoma: Influence of prior exposure to rituximab on outcome (a GEL/TAMO study). Ann Oncol 2008; 19 (suppl 4): S149, abstr 216.

  • Matutes E, Oscier D, Montalban C, Beger F, Callet-Bauchu E, Dogan A, Felman P, Franco V, Iannitto E, Mollejo M, Tapadaki T, Remstein ED, Salar A, Dolé F, Stamapoulos K, Thieblemont C, Traverse-Gjehen A, Wotherspoon A, Coiffier B, Piris MA. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia, 2008; 22; 487-495

  • Persistent monoclonality after histological remission in gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy and/or surgery: influence of t(11;18)(q21;q21)
    Santon A, García-Cosio M, Bellosillo B, Rodriguez P, Cristobal E, Serrano S, Besses C, Abraira V, Salar A, Montalban C.
    Leukemia & Lymphoma, 2008; 49; 1561-1522

  • A Martín, E Conde, E González Barca, MA Canales, G Deben, R Andreu, A Salar, P García Sánchez, S Nistal, MJ Requena, EM Donato, JA González, A León, C Ruiz, C Grande, R Arranz, S Durán, S Ortegón, JN Rodríguez, V Sandoval, MA Andreu, T Bernal, MT Hernández, MD Caballero. Grupo Español de Linfomas GEL-TAMO. R-ESHAP como régimen de rescate en pacientes con Linfoma B Difuso de Células Grandes: Estudio observacional retrospectivo sobre su eficacia y toxicidad. Haematologica 2007, 92, Extraordinario 2: C-079. 

  • Reyes Arranz, Eulogio Conde, Carlos Grande, Maria Victoria Mateos, Marco Gandarillas, Carmen Albo, Juan J. Lahuerta, José M. Fernández-Rañada, Miguel T. Hernández, Natalia Alonso, José A. García Vela, Sebastián Garzón, José Rodríguez, Dolores Caballero, on behalf of the Grupo Español de Linfomas ? Trasplante Auto´ logo de Médula Ósea (GEL–TAMO)Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/ autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL–TAMO Study Group. European Journal of Haematology. Accepted for publication: 1 Diciembre 2007

  • J. Rodríguez, E. Conde, A. Gutiérrez, R. Arranz, A. León, J. Marín, M. Bendandi, C. Albo, M.D. Dolores. On behalf of the Grupo Español de Linfomas/Trasplante Autólogo de Médula ösea. The results of consolidation with autologous stem-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann Oncol. January 2007

  • J. Rodríguez, E. Conde, A. Gutiérrez, R. Arranz, M. Gandarillas, A. León, J. Ojanguren, A. Sureda, D. Carrera, M. Bendandi, J. Moraleda, J.Mª Ribera, C. Albo, A. Morales, J.C. García, P. Fernández, G. Cañigral, J. Bergua, Mª D. Caballero. On behalf of the Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO Spanish lymphoma/autologous marrow transplant study group). Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. The GELTAMO experience. European Journal of Haematology, 78, 290-296, 2007

  • D. Serrano, R. Carrión, P. Balsalobre, P. Miralles, J. Berenguer, I. Buño, A. Gómez-Pineda, J.Mª Ribera, E. Conde, J.L. Díez-Martín on behalf of Spanish Cooperative Groups GELTAMO and GESIDA. HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Experimental Hematology. 2005; 33: 487-494.

  • A.Sureda, M. Constans, A. Iriondo, R. Arranz, M.D. Caballero, M.J. Vidal, J. Petit, A. López, J.J. Lahuerta, E. Carreras, J. García-Conde, J. García-Laraña, R. Cabrera, I. Jarque, D. Carrera, J.C. García-Ruiz, M.J. Pascual, J. Rifón, J.M. Moraleda, K. Pérez-Equiza, C. Albó, J. Díaz-Mediavilla, A. Torres, J. Besalduch, J. Marín, M.V. Mateos, J.M. Fernández-Rañada, J. Sierra, E. Conde for The Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO) Cooperative Group. Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse. Ann Oncol. Feb. 2005;

  • J. Rodríguez, M. Caballero, A. Gutierrez, J. Marín, R. Arranz, J. Lahuerta, J. Sierra, A. López-Guillermo, A.. Sureda, E. Carrerras, A. Leon, A. Fernández de Sevilla, J. Zuazu, M. Sanz, G. García-Laraña, M. Bendandi, R. Varela, M Gandarillals, J. San Miguel, E. Conde, “Long-term follow-up of autologous stem cell transplantation (ASCT) in patients with peripheral T-cell lymphoma (OTCL)”: the Spanish Lymphoma Cooperative Group (GEL-TAMO) experience Ann Oncol 2005 16 (5): 56 v

  • J. Rodríguez, M. Caballero, A. Gutierrez, J. Marín, R. Arranz, J. Lahuerta, J. Sierra, A. López-Guillermo, A.. Sureda, E. Carrerras, A. Leon, A. Fernández de Sevilla, J. Zuazu, M. Sanz, G. García-Laraña, M. Bendandi, R. Varela, M Gandarillals, J. San Miguel, E. Conde, Hematology-Oncology, On behalf of Spanish Lymphoma Cooperative Group (GEL-TAMO) Spain. “Front-line autologous stem cell transplantation (ASCY) improves the outcome of peripheral T-cell lymphoma (OTCL) in first remissión patient presenting with unfavourable prosgnostic factor” . Ann Oncol 2005 16 (5)

  • M.D. Caballero, R. Arranz, J. Rodríguez, M.L. Gutiérrez, C. Grande, M. Gandarillas, C. Albo, S. Garzón, M.T. Hernández, J.A. García Vela, P. Fernández Abellán, J.L. Bello, M.L. Amigo and E. Conde. On behalf on the GEL/TAMO Group. Treatment Stratification According to Early Response to Mega-CHOP, Based on CT and Gallium67 Scan (G67S) with or without IFE Salvage Therapy Followed by Peripheral Autologous Stem Cell Transplant (PBSCT) in Patient with Poor Prognosis Aggressive Lymphoma. A Preliminary Report from a Porspective GELTAMO Trial. Ann Oncol 2005, 16 (5): v184.

  • J.L. Diez-Martin, R. Carrión, J. Anguita, P. Balsalobre, P. Miralles, J. Berenguer, I. Buno, A. Gómez-Pineda, E. Conde, R. Varela, J. Mª Ribera, I. Espigado, L. Escoda, J. Loscertales, D. Serrano. On behalf of Spanish Groups GELTAMO-GESIDA. Does Highly Active Anti-Retroviral Therapy (HAART) Delay Myeloid, Engraftment after Autologous Stem Cell Transplant (ASCT) in HIV Associated Lymphoma (HIV+Ly) Patients?. Blood. Vol. 106, 11; 502a

  • J. Rodríguez, D. Caballero, A. Gutiérrez, M. Gandarillas, A. León, Jesús Ojanguren, A. Sureda, A. Lopez-Guillermo, D. Carrera, M. Bendandi, R. Arranz, J. Moraleda, J. Mª Ribera, C. Albo, A. Morales, J. C. García, P. Fernández, G. Cañigral, J. Bergua, E. Conde. For Spanish Group GELTAMO Prolonged Survival in Patients with angioimmunoblastic T-Cell Lymphoma (AIL) after High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT). The GELTAMO experience. Blood. Vol. 106, 11; 589a

  • E. Conde, R. Arranz, J. Rodríguez, María L. Gutiérrez, C. Grande, M. Gandarillas, C. Albo, J. L. Bello, S. Garzón, M. T. Hernández, J. A. García-Vela, P. Fernández, María L. Amigo, D. Caballero. Treatment Stratification According to Early Response to Mega-CHOP, Based on CT and Gallium67 Scan (G67S) with or without IFE Salvage Therapy Followed by Peripheral Autologous Stem Cell Transplant (PBSCT) in Patient with Poor Prognosis Aggressive Lymphoma. A Preliminary Report from a Prospective GELTAMO Trial. Blood. Vol. 106, 11; 932a

  • . Rodríguez, M.D. Caballero, A. Gutiérrez, C. Solano, R. Arranz, J.J. Lahuerta, J. Sierra, M. Gandarillas, J.A. Pérez-Simón, J. Zuazu, A. López-Guillermo, A. Sureda, E. Carreras, J. García-Laraña, J. Marin, J.C. García, A. Fernández Sevilla, J. Rifón, R. Varela, on behalf of the GEL/TAMO Spanish Group.Autologous stem-cell transplantation in diffuse large B-cell-non-Hodgkin’s lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience. Ann Oncol. 2004; 15: 1504-1509

  • M. Constans, A. Sureda, R. Arranz, MD Caballero, JJ. Lahuerta, J. Hernández-Boluda, M. Vidal, G. García-Laraña, J. Riffón, J. Ribera, P. Fernández-Abellán, J. Moraleda, M. Bernal, M. Mateos, M. Martín-Mateos, R. Córdoba, J. García-Conde, J. Sierra, E. Conde, Grupo GEL/TAMO “Prognostic factors effecting long-term outcome in patients with Hodgkin Lymphoma who relapse after autologous stem cell transplantation” Bone Marrow Transplant 2004; 33 (1): 6.

  • J. L. Diez-Martín, P. Balsalobre, P Miealles, A Gómez-Pineda, R. Carrión, I. Buño, S Resino, E. Conde, JM Ribera, D. Serrano, J. Beremguer GEL/TAMO and GESDIDA“Efficacy of autologous stem cell transplant in aids-relalted lymphoma patients” Bone Marrow Transplant 2004; 33 (1): 35.

  • M. Constans, A- Sureda, R. Arranz, MD. Caballero, JJ. Lahuerta, JC. Hernández-Boluda, MJ Vidal, J. García.Laraña, J. Rifón, JM Ribera, P. Fernández-Abellán, JM Moraleda, MR Bernal, MV Mateos, M Martín-Mateos, R. Córdoba, J. García-Conde, J. Sierra, E. Conde por Sapnish Cooperative (GEL/TAMO) “Secondary Malignancies after autologous Stem Cell trasplantation for Hodgkin´s Lymphoma: Incidence and Analysis Risk Factors” Blood. 2004; 104, 11 (1): 21 a

  • M. Constans, A- Sureda, R. Arranz, MD. Caballero, JJ. Lahuerta, JC. Hernández-Boluda,MJ Vidal, J. García.Laraña, J. Rifón, JM Ribera, P. Fernández-Abellán, JM Moraleda, MR Bernal, MV Mateos, M Martín-Mateos, R. Córdoba, J. García-Conde, J. Sierra, Eulogio Conde por Sapnish Cooperative (GEL/TAMO)“Pronostic Factor and Long-Term Outcome for Patients with Hodgkin´s Lymphoma Who Relapse after an Autologous Stem Cell Transplantation” Blood. 2004; 104, 11 (1): 458-459ª

  • M. Constans, A. Sureda, M.J. Terol, R. Arranz, M.D. Caballero, A. Iriondo, I. Jarque, E. Carreras, J.M. Moraleda, D. Carrera, A. León, A. López, C. Albo, J. Díaz-Mediavilla, P. Fernández-Abellán, J.C. García-Ruiz, F. Hernández-Navarro, R. Mataix, J. Petit, M.J. Pascual, J. Rifón, J. García-Conde, J.M. Fernández-Rañada, M.V. Mateos, J. Sierra & E. Conde. On behalf of the GEL/TAMO Cooperative Group. Autologous stem cell transplantation for primary refractory Hodgkin’s disease: results and clinical variables affecting outcome. Annals of Oncology 2003; 14: 745-51

  • M.D. Caballero, J.A. Pérez-Simón, a. Iriondo, J.J. Lahuerta, J. Sierra, J. Marín, M. Gandarillas, R. Arranz, J. Zuazu, V. Rubio, A. Fernández de Sevilla, E. Carreras, J. García-Conde, J. García-Laraña, C. Grande, A. Sureda, M.J. Vidal, J. Rifón, C. Pérez-Equiza, R. Varela, J.M. Moraleda, J.C. García Ruiz, C. Albo, R. Cabrera, J.F. San Miguel & E. Conde. On behalf of the Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea Spanish Cooperative Group. High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL/TAMO Spanish Cooperative Group.Annals of Oncology 2003; 14: 140-51 (ISSN:0923-7534) Edt.D.J. Kerr- Rd.

  • Juan José Lahuerta, Carlos Grande, Joaquín Martínez-Lopez, Javier de la Serna, Rosa Toscano, María Cruz Ortiz, Santiago Larregla, Eulogio Conde, Andrés Insunza, José David Gonzalez-San Miguel, Juan Bargay, Rafael Cabrera, Juan Carlos García-Ruiz, Carmen Albó, Luis García-Alonso, Fernando Solano, Pilar Vivancos, Angel León and Jesús San Miguel. Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos /Trasplante Autólogo de Médula Ósea phase II trial. Br J Hemtol 2003; 120:296-303

  • J. Rodríguez, MD Caballero, A. Gutierrez, A. Marín, JJ Lahuerta, E. Carreras, A. León, R. Arranz,  A. Fernández de Sevilla,  J. Zuazu,  J. García-Laraña, J. Rifón, R. Varela,   M Gandarillas, J San Miguel, E. Conde. High dose chemotherapy and autologous stem cell transplantation in  peripheral T-cell lymphoma : The GEL-TAMO experience. Ann Oncology 2003; 14:1768-75 (ISSN:0923-7534) Edt.D.J. Kerr- Rd. Board –Oxford

  • E. Conde, A. Insunza, JJ. Lahuerta, A. Sureda, D. Caballero, R. Arranz, F. Marco, J. García-Conde, MJ. Vidal, M. Gandarillas, E. Carreras, A. León, A. Bermúdez , J. Zuazu, A. Fernández-Sevilla, J. García-Laraña, L. Gonzalez-Ponte, D. Carrera, J. Rodríguez, P. Giraldo, C. Grande,  L. Palomera, R. Cabrera, MR. Varela, C. Pérez-Equiza, JM. Moraleda, F. Hernández, A. Iriondo, J. Rifón, JL. Bello, C. Albo, JC. García Ruiz, JA. García Vela, L. Hernández Nieto, JM. Fernández-Rañada, J. San Miguel, J. Sierra, A. Zubizarreta  for the GEL/TAMO Spanish Cooperative Group (Grupo Español de Linfomas / Trasplante Autólogo de Médula Ósea). Autologous stem cell transplantation (ASCT) in 419 patients with follicular lymphoma (FL). Hospital Universitario M. Valdecilla. Santander. Spain. 44th Annual Meeting of the American society of Hematology. Diciembre 6-10, 2002. Philadelphia-Pennsylvania Abstracts 2528. Blood Vol. 100. N 11-1º. Pag. 642a.

  • E. Conde, F. Marco, D. Caballero, R. Arranz, JJ. Lahuerta, A. Sureda, A. Bermúdez, f. Bosch, J. García-Conde, J. Marín, M. Gandarillas, A. Insunza, A. León, J. Zuazu, J. Petit, J. García-Laraña, L. González-Ponte, D. Carrera, D. Rubio-Felix, C. Grande, M. Gutiérrez, MR. Varela, C. Pérez-Equiza, J. Rifón, J.L. Bello, C. Albo, J.C. García Ruiz, J. Besalduch, J. San Miguel, JM. Fernández-Rañada, J. Sierra, A. Zubizarreta for the GEL/TAMO Spanish Cooperative Group (Grupo Español de Linfomas/Trasplante Autológo de Médula Ósea). Hospital U. Marqués de Valdecilla. Santander. Spain. 44th Annual Meeting of the American society of Hematology. Diciembre 6-10, 2002. Philadelphia-Pennsylvania Abstracts 2529. Blood Vol. 100. N 11-1º. Pag. 643a.

  • A. Sureda, R. Arranz, A. Iriondo, E. Carreras, JJ. Lahuerta, J. García-Laraña, I. Jarque, MD. Caballero, C. Ferrà, A. López, J. García-Laraña, R. Cabrera, D. Carrera, MD. Ruiz-Romero, A. León, J. Rifón, J. Díaz-Mediavilla, R. Mataix, M. Morey, JM. Moraleda, A. Altés, A. López-Guillermo, J. de la Serna, JM. Fernández-Rañada, J. Sierra, E. Conde for the Spanish Cooperative Group GELTAMO. Autologous Stem-Cell Transplantation for Hodgkin’s Disease: Results and Prognostic Factors in 494 patients from the Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea Spanish Cooperative Group. Journal of Clinical Oncology, Marzo 2001; Vol 19, No 5: pp 1395-1404.

  • Caballero D, Pérez-Simón J.A, García-Laraña J, Gandarillas M, Marín J, Lahuerta JJ, Arranz R, Rubio V, García-Conde J, Zuazu J, Vázquez L, Montserrat E, Grañena A, Sanz MA, Mataix R, Maldonado J, Rifón J, Sierra J, Carrera D, Moraleda JM, Conde E. High dose therapy in large cell lymphoma: analysis of prognostic factors in 452 patients of GEL-TAMO Restry. Bone Marrow Transplant 2001; 27: S14.

  • Guglielmi C, Gómez F, Conde E. Prognostic evaluation in adults with diffuse large B-cell lymphoma treated with autologous stem cell transpalntation at first sensitive relapse.  Bone Marrow Transplant 2001; 27: S259-S260.

  • Rodriguez J, Caballero D, Solano C, Lahuerta JJ, Arranz R, Sureda A, Marín J, García-Laraña J, López-Guillermo A, San Miguel J, Conde E. High-dose chemotherapy (HDC) and autologous stem cell transplantation (ASCT) in patients with primary refractory aggressive non-Hodgkin´s lymphoma. Bone Marrow Transplant 2001; 27: S260-S261.

  • Sureda A, Arranz R, García-Conde J, Caballero D, Iriondo A, Jarque I, López-Guillermo A, León A, Carrera D, López A, Ruiz MD, Díaz-Mediavilla J, Grañena A, Hernández-Navarro F, Mataix R, Moraleda JM, Albo C, Pérez-Equiza K, Sierra J, Fernández-Rañada JM, Solano C, Regadera A, Carreras E, Conde E. High dose therapy with autologous stem cell transplantation in primary refractory Hodgkin´s disease: Experience of the Spanish GEL/TAMO group. Bone Marrow Transplant 2001; 27: S269.

  • Salar A, Sierra J, Gandarillas M, Caballero D, Marín J, Lahuerta JJ, García-Conde J, Arranz R, León A, Zuazu J, García-Laraña J, López-Guillermo A, Sanz MA, Grañena A, García JC, Conde E for the GEL/TAMO Spanish Cooperative Group. Autologous stem cell transplantation for clinically agressive non-Hodgkin´s lymphoma: the role of preparative regimens. Bone Marrow Transplant 2001; 27:405–412.

  • Marco F, Caballero D, Arranz R, Lahuerta JJ, Sureda A, García-Laraña J, Gandarillas M, Cabrera R, León A, Muruzabal MJ, Zuazu J, Albo C, Bermúdez A, Marín J, Moraleda JM, Varela MR, Carreras E, Fernández-Sevilla A, Rifón J, Campo C, Pascual MJ, García JC, García-Conde J, Carrera D, Pérez-Eqiuza K, Bello JL, Conde E. Secondary neoplasms after autologous transplantation in patients with lymphoma. Blood 2001; 98:369

  • Rodriguez J, Caballero D, Gutierrez A, Sierra J, López-Guillermo A, Marín J, Sarra J, Lahuerta JJ, Rifón J, Conde E. Results of high dose chemotherapy and autologous stem cell transplantation in patients with pheripheral T-cell lymphoma. The Spanish Lymphoma Cooperative Group experience (GEL/TAMO). Blood 2001; 98:680

  • A. Salar, J. Sierra, D. Caballero, J. Marín, JJ Lahuerta, J. García-Conde, R. Arranz, A. León, J. Zuazu, J. García-Laraña, JC. García, MA. Sanz, A. Grañena, E. Montserrat, E. Conde. The GEL/TAMO Spanish Cooperative Group. Autologous stem cell transplantation for clinically aggressive non-Hodkin’s Lymphoma: The role of preparative regimen. The Hematology Journal, Junio 2000; 1 (supp 1):253.

  • Guglielmi C, Gomez F, Conde E. Factors influencing the outcome of autologous stem cell transplant at first sensitive relapse in 247 adults with diffuse large B-cell lymphoma. Blood 2000, 96:794a.

  • Conde E, García-Conde J, Caballero D, Arranz R, Sierra J, Gandarillas M, García JM, Vidal MJ, Lahuerta JJ, López-Guillermo A, Albo C, García-Laraña J, Marco F, Varela MR, Rifón J, Zuazu J, Fernández-Sevilla A, Campo C. Autologous stem cell transplantation (ASCT) for mediastinal large B-cell lymphoma with sclerosis (MLBCL). Blood 2000, 96:796a.

  • Sanz Rodríguez C, Sanchez A, Rodríguez F, Gandarillas M, Conde E, Arranz R. Chemotherapy plus interferon-"-2b vs. high-dose therapy for response consolidation in low grade non-hodgkin’s lymphoma: Results of a retrospective case control study. On behalf of the GEL/TAMO Spanish cooperative Group and the LNH-PRO Study Group. Spain. Blood 2000; 96:791a.

  • A. Sureda, R. Arranz, R. Cabrera, J. García Laraña, A. Iriondo, JJ. Lahuerta, A. León, A. López, R. Mataix, JM. Moraleda, MD Ruiz-Romero, E. Carreras, J. García-Conde, I. Jarque, MD. Caballero, C. Ferrà, D. Carrera, J. Rifón, J. Díaz.-Mediavilla, M. Morey, A. López-Guillermo, J. De la Serna, JM. Fernández Rañada, J. Sierra, E. Conde for the GEL/TAMO Spanish cooperative group. Secondary Malignancies risk after Autologous stem cell transplantation (ASCT) for Hodgkin`s disease (HD). A retrospective analysis from the GEL/TAMO. En Bone Marrow Transplantation 2000; 25 (supp 1): S42.

  • E. Conde, J. Zuazu, A. López-Guillermo, J. García-Laraña, R. Arranz, J. Sierra, JJ. Lahuerta, D. Caballero, J. García-Conde, M. Gandarillas, MJ. Vidal, A. Grañena, J. Rifón, A. Torres, F. Hernández Navarro, JL. Bello, A. Iriondo. Autologous stem cell transplantation for lymphoblastic lymphoma. En Blood 1999; 94 (Suppl 1): 477a.

  • A. Sureda, R. Arranz, A. Iriondo, E. Carreras, J. Zuazu, JJ. Lahuerta, et al. High dose therapy with autologous stem cell transplantation in hodgkin's disease in first relapse: Experience of the Spanish Gel/tamo group. En Haematologica 1999; 84 (abst book): 1174.

  • E. Conde, JJ. Lahuerta, J. Sierra, R. Arranz, E. Montserrat, D. Caballero, J. García-Conde, M. Gandarillas, V. Rubio, J. Bueno, A. Grañena, J. García-Laraña, MJ. Vidal, D.Carrera, P. Giraldo, JM. Moraleda, J. Maldonado, F. Hernández, P. Vivancos, M. Gutierrez, MR. Varela, S. Larregla, A. Zubizarreta. High-Dose therapy and autologous stem cell transplantation (ASCT) in 210 patients with follicular lymphoma (FL). Annals of Oncology 1999. Volumen (Supl. 3); 10: 75.

  • MD. Caballero et al. High dose therapy with autologous stem cell support in 366 patients with large cell lymphoma. A retrospective analysis of the GELTAMO Spanish Cooperative Group. Annals of Oncology 1999. Volumen (Supl. 3); 10: 77.

  • E. Conde, F. Bosch, R. Arranz, D. Caballero, JJ. Lahuerta, J. García-Conde, JM. Fernández-Rañada, A. León, A. Iriondo, J. Besalduch, A. Grañena, D. Carrera, J. Marín, S. Brunet, J. Maldonado, JM. Moraleda, D. Rubio, J. Díaz Mediavilla, P. Vivancos, MA. Piris , E. Montserrat. High-Dose therapy and autologous stem cell transplantation in 56 patients with mantle cell lymphoma. Annals of Oncology 1999. Volumen (Supl. 3); 10: 78.

  • A. Sureda, R. Arranz, A. Iriondo, E. Carreras, A. López, JJ. Lahuerta, D. Caballero, J. Berlanga, J. García-Conde, D. Carrera, R. Cabrera, J. García-Laraña, J. Maldonado, J. Rifón, J. Díaz-Mediavilla, J. Besalduch, R. Varela, A. León, R. Mataix, JM. Moraleda, C. Herrera, E. Bengoechea, L. Palomera, C. Albo, JD. González, J. Ojanguren, JC. García, JM. Fernández-Rañada, J. Sierra, E.Conde for the GEL/TAMO. Autologous stem cell transplantation (ASCT) in Hodgkin's Disease (HD) after first relapse: Experience of the Spanish GELTAMO Group. Bone Marrow Transplant 1999 (Supl.1) ; 23:S105.

  • A. Sureda, R. Arranz, A. Iriondo, E. Carreras, JJ. Lahuerta, J. García-Conde, I. Jarque, D. Caballero, C. Ferrà, A. López, J. García-Laraña, R. Cabrera, D. Carrera, J. Maldonado, A. León, J. Rifón, J. Díaz-Mediavilla, R. Mataix, J. Besalduch, JM. Moraleda, A. López-Guillermo, R. Bornstein, JM. Fernández-Rañada, J. Sierra, E.Conde for the GEL/TAMO Spanish Group. Autologous stem cell transplants (ASCT) for Hodgkin's Disease (HD): Results and prognostic factors in 495 patients. Experience of the GELTAMO Spanish Group. Bone Marrow Transplant 1999 (Supl.1) ; 23:S105.

  • MD. Caballero, J. García-Laraña, M. Gandarillas, J. Marín, JJ. Lahuerta, R. Arranz, V. Rubio, J. García-Conde, J.Zuazu, L. Vazquez, E. Montserrat, A. Grañena, MA. Sanz, R. Mataix, J. Maldonado, J. Rifón, J. Sierra, D. Carrera, JM. Moraleda, JC García, E. Conde. High dose therapy with autologous stem cell support in 366 patients with large cell lymphoma. A retrospective analysis of the GELTAMO Spanish Cooperative Group. Bone Marrow Transplant 1999 (Supl.1) ; 23:S156.

  • JJ. Lahuerta, E. Conde, J. Sierra, R. Arranz, E. Montserrat, D. Caballero, J. García-Conde, M Gandarillas, V. Rubio, J. Bueno, A. Grañena, LG. Ponte, J. García-Laraña, MJ. Vidal, D. Carrera, D. Rubio-Félix, JM. Moraleda, J. Maldonado, F. Hernández, P. Vivancos, M. Gutierrez, MR. Varela, R. Bornstein, A. Zubizarreta. Autologous stem cell transplantation (ASCT) for Follicular Lymphoma (FL). The Experience of the GELTAMO Spanish Group. Bone Marrow Transplant 1999 (Supl.1) ; 23:S157.

  • E. Conde, F. Bosch, R. Arranz, D. Caballero, JJ. Lahuerta, J. García-Conde, J. Sierra, M. Gandarillas, JM. Fernández-Rañada, A. León, A. Iriondo, J. San Miguel, J. Besalduch, A. Grañena, D. Carrera, J. Marín, J. Maldonado, JM. Moraleda, D. Rubio-Félix, J. Díaz Mediavilla, J. Zuazu, P. Vivancos, L. Palomera, MA. Piris, E. Montserrat. Autologous stem cell transplantation (ASCT) for Mantle cell Lymphoma (MCL). The Experience of the GELTAMO Spanish Group. Bone Marrow Transplant 1999 (Supl.1) ; 23:S157.

  • E. Conde, JJ. Lahuerta, J. Sierra, R. Arranz , E. Montserrat, D. Caballero, J. García-Conde, M. Gandarillas, V. Rubio, J. Bueno, A. Grañena, L.G. Ponte, J. García-Laraña, MJ. Vidal, D.Carrera, D. Rubio-Felix, JM. Moraleda, J. Maldonado, F. Hernández, P. Vivancos, M. Gutierrez, MR. Varela, R. Bornstein, A. Zubizarreta. Autologous stem cell transplantation for follicular lymphoma. The experience of the GELTAMO Spanish Cooperative Group. Blood 1998;(Supl.1);92, NO 10: 1914.

  • E. Conde, F. Bosch, R. Arranz, D. Caballero, JJ. Lahuerta, J. García-Conde, J. Sierra, M. Gandarillas, JM. Fernández-Rañada, A. León, A. Iriondo, J. San Miguel, J. Besalduch, A. Grañena, D. Carrera, J. Marín, J. Maldonado, JM. Moraleda, D. Rubio-Felix, J. Díaz Mediavilla, J. Zuazu, P. Vivancos, L. Palomera, MA. Piris, E. Montserrat. Autologous stem cell transplantation for mantle cell lymphoma. The experience of the GELTAMO Spanish Cooperative Group. Blood 1998;(Supl.1);92, NO 10: 1915.

  • JJ. Lahuerta-Palacios, C. Grande, J de la Serna, R. Bornstein, J. Bargay, E. Conde, R. Toscano, MC. Ortiz, JD. González San Miguel, C. Albo, S. Larregla, R. Ayala, J. Besalduch and A. Iriondo (Intr. By JL. Díez). In behalf of the Spanish Cooperative Group GEL/TAMO, Madrid. Spain. High-dose cyclophosphamide, BCNU and VP-16 (CBV) supported with second autologous hemopoietic transplant (Tx) in multiple myeloma (MM) chemosensitive to melphalan 200 mg/m2. An interim report. Blood 1997 (Supl. 1); 90, NO 10: 1019.

  • E. Conde et al. Autologous stem cell transplantation for mantle cell lymphoma. The experience of the GEL/TAMO Spanish Cooperative Group. E. Conde, F. Bosch, R. Arranz, D. Caballero, JJ. Lahuerta, J. García-Conde, JM. Fernández-Rañada, A. León, A. Iriondo, J. Besalduch, A. Grañena, D. Carrera, J. Marín, S. Brunet, J. Maldonado, JM. Moraleda, D. Rubio, J. Díaz Mediavilla, P. Vivancos, MA. Piris and E. Montserrat. Blood 1997 (Supl. 1); 90, NO 10: 1020.

  • A. Sureda, J. García-Conde, J. Sierra, JF.Tomás, I. Jarque, E. Conde, D. Caballero, A. León-Lara, J. Maldonado, M. Callís, D. Carrera, A. López, R. Mataix, JM. Moraleda, A. Pérez-López, R. Arranz, S. Brunet, E. Montserrat, C. Solano, MA. Sanz and A. Domingo-Albós. Autologous stem cell transplantation in primary refractory Hodgkin's disease: Retrospective analysis of 44 patients from the Spanish GEL/TAMO Cooperative Group. Blood 1997 (Supl. 1); 90, NO 10: 4584.

  • A. Sureda, R. Mataix, F. Hernández-Navarro, I. Jarque, JJ. Lahuerta, JF. Tomás, S. Brunet, D. Caballero, E. Conde, A. León, MN. Fernández, A. López, J. Maldonado, E. Bengoechea, M. Callís, D. Carrera, J. García-Conde, J. García-Laraña, JM. Moraleda, M. Morey, J. Rifón, J. Sierra, A. Torres, A. Domingo-Albós. Autologous steam cell trasnsplantation for poor prognosis hodgkin's disease in first complete remission: A retrospective study from the Spanish Cooperative Group GEL/TAMO. Bone Marrow Transplant 1997 (Supl. 1); 19:S198.

  • A. Sureda, R. Mataix, F. Hernández-Navarro, I. Jarque, JJ. Lahuerta, JF. Tomás, S. Brunet, D. Caballero, E. Conde, A. León, MN. Fernández, A. López, J. Maldonado. E. Bengoechea, M. Callís, D. Carrera, J. García-Conde, J. García-Laraña, JM. Moraleda, M. Morey, J. Rifón, J. Sierra, A. Torres, A. Domingo-Albós, for the Spanish Cooperative Group. Autologous steam cell trasnsplantation for poor prognosis hodgkin's disease in first complete remission: A retrospective study from the Spanish GEL/TAMO Cooperative Group. Bone Marrow Transplant 1997; 20:283-288.

  • JJ. Lahuerta-Palacios, C. Grande, J. de la Serna, J. Bargay, R. Bornstein, MC. Ortiz, R. Toscano, S. Larregla. High-dose cyclophosphamide, BCNU and VP-16 (CBV) supported with a second autologous hemopoietic transplant (Tx) in multiple myeloma (MM) chemosensitive to melfalan 200 mg/m2 (MEL200). First interim report. (Spanish Cooperative Group GEL/TAMO and GETH study). Hematology Units, Hospital "12 de Octubre" (Madrid) and Hospital "Son Dureta (Palma de Mallorca), Spain. Br J Haematol 1996; 93 (Supl. 2):83.

  • A. Domingo, A. Sureda, A. Iriondo, JF. Tomás, E. Bengoechea, D. Caballero, J. Zuazu, F. Hernández, J. García-Laraña, J. Sierra, A. Torres, E. Rocha, C. Solano, R. Mataix, J. Maldonado, A. León, J. Besalduch, S. Brunet, J. Rifón, MA. Sanz, JM. Fernández, E. Conde, J. Odriozola, J. García-Conde. Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea GEL/TAMO. High dose chemo/radiotherapy with autologous rescue for Hodgkin's disease patients in 2nd or 3rd complete remission. Bone Marrow Transplant (Supl.2) 1995; 15:S94.

  • A. Domingo, A. Sureda, A. Iriondo, JF. Tomás, A. León, R. Mataix, MA. Sanz, E. Bengoechea, D.Caballero, F. Hernández, J. García-Laraña, J. Sierra, A. Torres, E. Rocha, C. Solano, J. Maldonado, J. Besalduch, S. Brunet, J. Rifón, JM. Ferández, E. Conde, J. Odriozola, J. García-Conde. Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea GEL/TAMO. High dose chemo/radiotherapy with autologous transplantation for bad prognosis Hodgkin's disease patients in 1st complete remission. Bone Marrow Transplant (Supl. 2) 1995; 15:S39.

  • A. Iriondo, J. García-Conde, A. Domingo (Por el Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea G EL/TAMO.) Bone Marrow Transplantation in Hodgkin's disease: When should it be considered?. Hematology Reviews 1994; 8:313-321.
  • E. Conde, J. Sierra, A. Iriondo, A. Domingo, J. García-Laraña, J. Marín, D. Caballero, F. Martínez, A. León, J. García-Conde, F. Hernández, D. Carrera, R. Mataix, J. Zuazu, B. Cuesta, J. Díaz Mediavilla, J. Lahuerta, C. Richard, J. Baro, E. Montserrat,. Prognostic factors in patients who received autologous bone marrow transplantation for non-hodgkin's lymphoma. Report of 104 patients from the Spanish Cooperative Group GEL/TAMO. Bone Marrow Transplant 1994; 14:279-286.

  • J. Sierra, E. Conde, J. Garcìa-Laraña, A. Iriondo, A. Domingo, J. Marín, D. Caballero, F. Martínez, A. León, J. García-Conde, F. Hernández, JC. Reverter, D. Carrera, C. Richard, J. Zuazu, J. Baro, E. Rocha, J. Díaz Mediavilla, C. Rozman, E. Montserrat. Frozen vs. nonfrozen bone marrow for autologous transplantation in lymphomas: A comparative study from the Spanish GEL/TAMO Cooperative Group.Ann Hematol 1993; 67:111-114.

  • J. Sierra, E. Conde, E. Montserrat (Por el Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea GEL/TAMO): Autologous bone marrow transplantatio for non-Hodgkin's lymphoma in first remission. Blood 1993; 81:1968-1969.

  • J. Baro, C. Richard, J. Sierra, J. García-Conde, J. García-Laraña, E. Rocha, C. Solano, D. Caballero, D. Carrera, A. León, J. Zuazu, F. Martínez, A. Domingo, F. Hernández, J. Marín, A. Iriondo, E. Montserrat, E. Conde: Autologous bone marrow transplantation in adult lymphoblastic lymphoma. Bone Marrow Transplant 10:33-38, 1992.

Nuestro sitio web utiliza cookies propias y de terceros para mejorar nuestros contenidos y servicios mediante el análisis de sus hábitos de navegación. Al aceptar el presente aviso entendemos que da su consentimiento a nuestra Política de cookies.

  Aceptar Política de cookies